Cancer Gene Therapy Market By Therapy and End User - Global Industry Analysis & Forecast to 2027
Published On : January 2019 Pages : 175 Category: Automotive & Transportations Report Code : AT012401
Cancer Gene Therapy Market By Therapy (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer) End User (Diagnostics Centers, Hospitals, Research Institutes) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Cancer Gene Therapy Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Cancer could be characterized as uncontrolled cell development in the body prompting malfunction of organs. If the condition is untreated, it causes the death of the patient. Uncontrolled development of cell is overseen by the body in a few different ways, one of them is by conveying white platelets to distinguish and annihilate these destructive cells. It has been found that the resistant framework could be controlled to impact cancerous cells to wreck it.
Drivers and Restraints
The rising field of disease Gene Therapy offers shifted potential treatments. Gene therapy includes a scope of treatment types, which utilize hereditary material to change cells either in vivo or in vitro to help treat the sickness. Cancer Gene Therapy appeared in different in vitro and preclinical testing. Preclinical testing for disease quality treatment has been performed on pancreatic cancer, glioma, liver malignancy, and numerous different cancers. Increment in predominance of cancer, ascend in government financing and activities, development in pipeline of cancer gene therapy products, and joint efforts to create and dispatch quality treatment items are a few components driving the market.
Regional Insights
The U.S. leads the cancer gene therapy market attributable to its expansion in subsidizing for research and improvement and other government activities.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- GlaxoSmithKline
- Merck
- Shanghai Sunway Biotech
- Shenzhen SiBiono GeneTech
- OncoGenex Pharmaceuticals
- Adaptimmune
- Bluebird bio, Inc
- Celgene
- BioCancell
- SynerGene Therapeutics
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Cancer Gene Therapy Market, By Therapy, Estimates and Forecast, 2017-2027 ($Million)
· Oncolytic Virotherapy
· Gene Induced Immunotherapy
· Gene Transfer
· Cancer Gene Therapy Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
· Diagnostics Centers
· Hospitals
· Research Institutes
· Cancer Gene Therapy Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
· North America
§ North America Cancer Gene Therapy Market, By Country
o U.S. Cancer Gene Therapy Market
o Canada Cancer Gene Therapy Market
o Mexico Cancer Gene Therapy Market
· Europe
§ Europe Cancer Gene Therapy Market, By Country
o Germany Cancer Gene Therapy Market
o UK Cancer Gene Therapy Market
o France Cancer Gene Therapy Market
o Russia Cancer Gene Therapy Market
o Italy Cancer Gene Therapy Market
o Rest of Europe Cancer Gene Therapy Market
· Asia-Pacific
§ Asia-Pacific Cancer Gene Therapy Market, By Country
o China Cancer Gene Therapy Market
o Japan Cancer Gene Therapy Market
o South Korea Cancer Gene Therapy Market
o India Cancer Gene Therapy Market
o Southeast Asia Cancer Gene Therapy Market
o Rest of Asia-Pacific Cancer Gene Therapy Market
· South America
§ South America Cancer Gene Therapy Market
o Brazil Cancer Gene Therapy Market
o Argentina Cancer Gene Therapy Market
o Columbia Cancer Gene Therapy Market
o Rest of South America Cancer Gene Therapy Market
· Middle East and Africa
§ Middle East and Africa Cancer Gene Therapy Market
o Saudi Arabia Cancer Gene Therapy Market
o UAE Cancer Gene Therapy Market
o Egypt Cancer Gene Therapy Market
o Nigeria Cancer Gene Therapy Market
o South Africa Cancer Gene Therapy Market
o Rest of MEA Cancer Gene Therapy Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Cancer Gene Therapy Market, By Therapy
5.1. Introduction
5.2. Global Cancer Gene Therapy Revenue and Market Share by Therapy (2017-2027)
5.2.1. Global Cancer Gene Therapy Revenue and Revenue Share by Therapy (2017-2027)
5.3. Oncolytic Virotherapy
5.3.1. Global Oncolytic Virotherapy Revenue and Growth Rate (2017-2027)
5.4. Gene Induced Immunotherapy
5.4.1. Global Gene Induced Immunotherapy Revenue and Growth Rate (2017-2027)
5.5. Gene Transfer
5.5.1. Global Gene Transfer Revenue and Growth Rate (2017-2027)
6. Cancer Gene Therapy Market, By End User
6.1. Introduction
6.2. Global Cancer Gene Therapy Revenue and Market Share by End User (2017-2027)
6.2.1. Global Cancer Gene Therapy Revenue and Revenue Share by End User (2017-2027)
6.3. Diagnostics Centers
6.3.1. Global Diagnostics Centers Revenue and Growth Rate (2017-2027)
6.4. Hospitals
6.4.1. Global Hospitals Revenue and Growth Rate (2017-2027)
6.5. Research Institutes
6.5.1. Global Research Institutes Revenue and Growth Rate (2017-2027)
7. Cancer Gene Therapy Market, By Region
7.1. Introduction
7.2. Global Cancer Gene Therapy Revenue and Market Share by Regions
7.2.1. Global Cancer Gene Therapy Revenue by Regions (2017-2027)
7.3. North America Cancer Gene Therapy by Countries
7.3.1. North America Cancer Gene Therapy Revenue and Growth Rate (2017-2027)
7.3.2. North America Cancer Gene Therapy Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Cancer Gene Therapy by Countries
7.4.1. Europe Cancer Gene Therapy Revenue and Growth Rate (2017-2027)
7.4.2. Europe Cancer Gene Therapy Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Cancer Gene Therapy by Countries
7.5.1. Asia-Pacific Cancer Gene Therapy Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Cancer Gene Therapy Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Cancer Gene Therapy by Countries
7.6.1. South America Cancer Gene Therapy Revenue and Growth Rate (2017-2027)
7.6.2. South America Cancer Gene Therapy Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Cancer Gene Therapy by Countries
7.7.1. Middle East and Africa Cancer Gene Therapy Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Cancer Gene Therapy Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. GlaxoSmithKline
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Revenue and Market Share
8.2. Merck
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Revenue and Market Share
8.3. Shanghai Sunway Biotech
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Revenue and Market Share
8.4. Shenzhen SiBiono GeneTech
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Revenue and Market Share
8.5. OncoGenex Pharmaceuticals
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Revenue and Market Share
8.6. Adaptimmune
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Revenue and Market Share
8.7. Bluebird bio, Inc
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Revenue and Market Share
8.8. Celgene
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Revenue and Market Share
8.9. BioCancell
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Revenue and Market Share
8.10. SynerGene Therapeutics
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Revenue and Market Share
9. Global Cancer Gene Therapy Market Competition, by Manufacturer
9.1. Global Cancer Gene Therapy Revenue and Market Share by Manufacturer (2017-2017)
9.2. Global Cancer Gene Therapy Price By Region (2017-2017)
9.3. Top 5 Cancer Gene Therapy Manufacturer Market Share
9.4. Market Competition Trend
10. Cancer Gene Therapy Market Forecast (2017-2027)
10.1. Global Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Cancer Gene Therapy Market Forecast by Regions (2017-2027)
10.2.1. North America Cancer Gene Therapy Market Forecast (2017-2027)
10.2.1.1. United States Cancer Gene Therapy Market Forecast (2017-2027)
10.2.1.2. Canada Cancer Gene Therapy Market Forecast (2017-2027)
10.2.1.3. Mexico Cancer Gene Therapy Market Forecast (2017-2027)
10.2.2. Europe Cancer Gene Therapy Market Forecast (2017-2027)
10.2.2.1. Germany Cancer Gene Therapy Market Forecast (2017-2027)
10.2.2.2. France Cancer Gene Therapy Market Forecast (2017-2027)
10.2.2.3. UK Cancer Gene Therapy Market Forecast (2017-2027)
10.2.2.4. Russia Cancer Gene Therapy Market Forecast (2017-2027)
10.2.2.5. Italy Cancer Gene Therapy Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Cancer Gene Therapy Market Forecast (2017-2027)
10.2.3. Asia-Pacific Cancer Gene Therapy Market Forecast (2017-2027)
10.2.3.1. China Cancer Gene Therapy Market Forecast (2017-2027)
10.2.3.2. Japan Cancer Gene Therapy Market Forecast (2017-2027)
10.2.3.3. Korea Cancer Gene Therapy Market Forecast (2017-2027)
10.2.3.4. India Cancer Gene Therapy Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Cancer Gene Therapy Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Cancer Gene Therapy Market Forecast (2017-2027)
10.2.4. South America Cancer Gene Therapy Market Forecast (2017-2027)
10.2.4.1. Brazil Cancer Gene Therapy Market Forecast (2017-2027)
10.2.4.2. Argentina Cancer Gene Therapy Market Forecast (2017-2027)
10.2.4.3. Columbia Cancer Gene Therapy Market Forecast (2017-2027)
10.2.4.4. Rest of South America Cancer Gene Therapy Market Forecast (2017-2027)
10.2.5. Middle East and Africa Cancer Gene Therapy Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Cancer Gene Therapy Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Cancer Gene Therapy Market Forecast (2017-2027)
10.2.5.3. Egypt Cancer Gene Therapy Market Forecast (2017-2027)
10.2.5.4. Nigeria Cancer Gene Therapy Market Forecast (2017-2027)
10.2.5.5. South Africa Cancer Gene Therapy Market Forecast (2017-2027)
10.2.5.6. Turkey Cancer Gene Therapy Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Cancer Gene Therapy Market Forecast (2017-2027)
10.3. Cancer Gene Therapy Market Forecast by Therapy (2017-2027)
10.3.1. Cancer Gene Therapy Forecast by Therapy (2017-2027)
10.3.2. Cancer Gene Therapy Market Share Forecast by Therapy (2017-2027)
10.4. Cancer Gene Therapy Market Forecast by End User (2017-2027)
10.4.1. Cancer Gene Therapy Forecast by End User (2017-2027)
10.4.2. Cancer Gene Therapy Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Cancer Gene Therapy Revenue and Revenue Share by Therapy (2017-2018)
Figure Global Oncolytic Virotherapy Revenue and Growth Rate (2017-2018)
Figure Global Gene Induced Immunotherapy Revenue and Growth Rate (2017-2018)
Figure Global Gene Transfer Revenue and Growth Rate (2017-2018)
Table Global Cancer Gene Therapy Revenue and Revenue Share by End User (2017-2018)
Figure Global Diagnostics Centers Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Figure Global Research Institutes Revenue and Growth Rate (2017-2018)
Table Global Cancer Gene Therapy Revenue by Regions (2017-2018)
Figure North America Cancer Gene Therapy Growth Rate (2017-2018)
Figure North America Cancer Gene Therapy Revenue and Growth Rate (2017-2018)
Figure North America Cancer Gene Therapy by Countries (2017-2018)
Figure North America Cancer Gene Therapy Revenue (Million USD) by Countries (2017-2018)
Figure United States Cancer Gene Therapy Growth Rate (2017-2018)
Figure United States Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Cancer Gene Therapy Growth Rate (2017-2018)
Figure Canada Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Cancer Gene Therapy Growth Rate (2017-2018)
Figure Mexico Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Cancer Gene Therapy Growth Rate (2017-2018)
Figure Europe Cancer Gene Therapy Revenue and Growth Rate (2017-2018)
Figure Europe Cancer Gene Therapy by Countries (2017-2018)
Figure Europe Cancer Gene Therapy Revenue (Million USD) by Countries (2017-2018)
Figure Germany Cancer Gene Therapy Growth Rate (2017-2018)
Figure Germany Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Cancer Gene Therapy Growth Rate (2017-2018)
Figure France Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Cancer Gene Therapy Growth Rate (2017-2018)
Figure UK Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Cancer Gene Therapy Growth Rate (2017-2018)
Figure Russia Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Cancer Gene Therapy Growth Rate (2017-2018)
Figure Italy Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Cancer Gene Therapy Growth Rate (2017-2018)
Figure Rest of Europe Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Cancer Gene Therapy Growth Rate (2017-2018)
Figure Asia-Pacific Cancer Gene Therapy Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Cancer Gene Therapy by Countries (2017-2018)
Figure Asia-Pacific Cancer Gene Therapy Revenue (Million USD) by Countries (2017-2018)
Figure China Cancer Gene Therapy Growth Rate (2017-2018)
Figure China Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Cancer Gene Therapy Growth Rate (2017-2018)
Figure Japan Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Cancer Gene Therapy Growth Rate (2017-2018)
Figure Korea Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Cancer Gene Therapy Growth Rate (2017-2018)
Figure India Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Cancer Gene Therapy Growth Rate (2017-2018)
Figure Southeast Asia Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Cancer Gene Therapy Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Cancer Gene Therapy Growth Rate (2017-2018)
Figure South America Cancer Gene Therapy Revenue and Growth Rate (2017-2018)
Figure South America Cancer Gene Therapy by Countries (2017-2018)
Figure South America Cancer Gene Therapy Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Cancer Gene Therapy Growth Rate (2017-2018)
Figure Brazil Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Cancer Gene Therapy Growth Rate (2017-2018)
Figure Argentina Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Cancer Gene Therapy Growth Rate (2017-2018)
Figure Columbia Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Cancer Gene Therapy Growth Rate (2017-2018)
Figure Rest of South America Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Cancer Gene Therapy Growth Rate (2017-2018)
Figure Middle East and Africa Cancer Gene Therapy Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Cancer Gene Therapy by Countries (2017-2018)
Figure Middle East and Africa Cancer Gene Therapy Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Cancer Gene Therapy Growth Rate (2017-2018)
Figure Saudi Arabia Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Cancer Gene Therapy Growth Rate (2017-2018)
Figure United Arab Emirates Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Cancer Gene Therapy Growth Rate (2017-2018)
Figure Egypt Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Cancer Gene Therapy Growth Rate (2017-2018)
Figure Nigeria Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Cancer Gene Therapy Growth Rate (2017-2018)
Figure South Africa Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Cancer Gene Therapy Growth Rate (2017-2018)
Figure Turkey Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Cancer Gene Therapy Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Table GlaxoSmithKline Cancer Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck Cancer Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Shanghai Sunway Biotech Cancer Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table OncoGenex Pharmaceuticals Cancer Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Adaptimmune Cancer Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bluebird bio, Inc Cancer Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Celgene Cancer Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table BioCancell Cancer Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table SynerGene Therapeutics Cancer Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Cancer Gene Therapy Market Share by Manufacturer
Figure Global Cancer Gene Therapy Revenue and Market Share by Manufacturer
Table Global Cancer Gene Therapy Price by Region (2017-2017)
Figure Top 5 Cancer Gene Therapy Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Cancer Gene Therapy Revenue (Millions USD) and Growth Rate (2018-2025)
Table Cancer Gene Therapy Market Forecast by Regions (2018-2025)
Figure North America Cancer Gene Therapy Market Forecast (2018-2025)
Figure United States Cancer Gene Therapy Market Forecast (2018-2025)
Figure Canada Cancer Gene Therapy Market Forecast (2018-2025)
Figure Mexico Cancer Gene Therapy Market Forecast (2018-2025)
Figure Europe Cancer Gene Therapy Market Forecast (2018-2025)
Figure Germany Cancer Gene Therapy Market Forecast (2018-2025)
Figure France Cancer Gene Therapy Market Forecast (2018-2025)
Figure UK Cancer Gene Therapy Market Forecast (2018-2025)
Figure Russia Cancer Gene Therapy Market Forecast (2018-2025)
Figure Italy Cancer Gene Therapy Market Forecast (2018-2025)
Figure Rest of Europe Cancer Gene Therapy Market Forecast (2018-2025)
Figure Asia-Pacific Cancer Gene Therapy Market Forecast (2018-2025)
Figure China Cancer Gene Therapy Market Forecast (2018-2025)
Figure Japan Cancer Gene Therapy Market Forecast (2018-2025)
Figure Korea Cancer Gene Therapy Market Forecast (2018-2025)
Figure India Cancer Gene Therapy Market Forecast (2018-2025)
Figure Southeast Asia Cancer Gene Therapy Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Cancer Gene Therapy Market Forecast (2018-2025)
Figure South America Cancer Gene Therapy Market Forecast (2018-2025)
Figure Brazil Cancer Gene Therapy Market Forecast (2018-2025)
Figure Argentina Cancer Gene Therapy Market Forecast (2018-2025)
Figure Columbia Cancer Gene Therapy Market Forecast (2018-2025)
Figure Rest of South America Cancer Gene Therapy Market Forecast (2018-2025)
Figure Middle East and Africa Cancer Gene Therapy Market Forecast (2018-2025)
Figure Saudi Arabia Cancer Gene Therapy Market Forecast (2018-2025)
Figure United Arab Emirates Cancer Gene Therapy Market Forecast (2018-2025)
Figure Egypt Cancer Gene Therapy Market Forecast (2018-2025)
Figure Nigeria Cancer Gene Therapy Market Forecast (2018-2025)
Figure South Africa Cancer Gene Therapy Market Forecast (2018-2025)
Figure Turkey Cancer Gene Therapy Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Cancer Gene Therapy Market Forecast (2018-2025)
Figure Global Cancer Gene Therapy Forecast by Therapy (2018-2025)
Figure Global Cancer Gene Therapy Market Share Forecast by Therapy (2018-2025)
Figure Global Cancer Gene Therapy Forecast by Therapy (2018-2025)
Figure Global Cancer Gene Therapy Forecast by End User (2018-2025)
Figure Global Cancer Gene Therapy Market Share Forecast by End User (2018-2025)
Figure Global Cancer Gene Therapy Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|